Announcements Trials
Browse Landscape

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 48NIH 4OTHER_GOV 3NETWORK 2INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Breast 2

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT04668521 2023-12-26

OVA360

Aspira Women's Health

Terminated
215 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT01273909 2014-06-06

Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment

The National Institute of Lymphology

Unknown
1,000 enrolled
BreastGynecologic

Breast Neoplasms, Lymphedema, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡